Schulze Stephan D, Bertelmann Thomas, Manojlovic Irena, Bodanowitz Stefan, Irle Sebastian, Sekundo Walter
Department of Ophthalmology, Philipps University of Marburg, Marburg, Germany.
Private Practice and Ambulatory Surgical Center, Bremen, Germany.
Clin Ophthalmol. 2015 Nov 6;9:2073-80. doi: 10.2147/OPTH.S90628. eCollection 2015.
To evaluate whether the use of balanced salt solution (BSS) or an ophthalmic viscoelastic device (OVD) during hydrophilic acrylic intraocular lens (IOL) implantation variously impacts corneal endothelial cell characteristics in eyes undergoing uneventful phacoemulsifications.
Prospective nonrandomized observational clinical trial. Patients were assigned either to the BSS plus(®) or to the OVD Z-Celcoat™ group depending on the substance used during IOL implantation. Corneal endothelium cell characteristics were obtained before, 1 week, and 6 weeks after surgery. Intraoperative parameters (eg, surgery time, phacoemulsification energy) were recorded.
Ninety-seven eyes were assigned to the BSS plus and 86 eyes to the Z-Celcoat group. Preoperative corneal endothelium cell density (ECD) and endothelium cell size were 2,506±310 cells/mm(2)/2,433±261 cells/mm(2) and 406±47 µm(2)/416±50 µm(2) (P=0.107/P=0.09). After 1 and 6 weeks, ECD decreased and endothelium cell size increased significantly in both groups (each P<0.001) without significant differences between both groups (each P>0.05). Irrigation-aspiration suction time (30.3±16.6 versus 36.3±14.5 seconds) and overall surgical time (7.2±1.2 versus 8.0±1.4 minutes) were significantly longer in the OVD Z-Celcoat group (each P<0.001). No complications or serious side effects occurred.
Implantation of a hydrophilic acrylic IOL under BSS infusion seems to be a useful and faster alternative in experienced hands without generating higher ECD loss rates.
评估在顺利进行超声乳化白内障吸除术的眼中,亲水性丙烯酸人工晶状体(IOL)植入过程中使用平衡盐溶液(BSS)或眼科粘弹性装置(OVD)是否会对角膜内皮细胞特征产生不同影响。
前瞻性非随机观察性临床试验。根据IOL植入过程中使用的物质,将患者分为BSS plus®组或OVD Z-Celcoat™组。在手术前、术后1周和6周获取角膜内皮细胞特征。记录术中参数(如手术时间、超声乳化能量)。
97只眼被分配到BSS plus组,86只眼被分配到Z-Celcoat组。术前角膜内皮细胞密度(ECD)和内皮细胞大小分别为2506±310个细胞/mm²/2433±261个细胞/mm²和406±47 µm²/416±50 µm²(P = 0.107/P = 0.09)。1周和6周后,两组的ECD均下降,内皮细胞大小均显著增加(各P<0.001),两组之间无显著差异(各P>0.05)。OVD Z-Celcoat组的冲洗-抽吸时间(30.3±16.6秒对36.3±14.5秒)和总手术时间(7.2±1.2分钟对8.0±1.4分钟)显著更长(各P<0.001)。未发生并发症或严重副作用。
在有经验的医生操作下,在BSS灌注下植入亲水性丙烯酸IOL似乎是一种有用且更快的选择,不会产生更高的ECD损失率。